Thoma Bravo, a leading software investment firm, is set to acquire NextGen Healthcare, Inc., a provider of healthcare technology solutions, for $23.95 per share in cash.
Upon completion of the transaction, NextGen Healthcare will become a privately held company.
The per share purchase price represents a 46.4 percent premium to the Company’s unaffected closing stock price on August 22 and a 39.2 percent premium to the 30-day volume-weighted average price for the period ending September 1.
“Under the terms of the agreement, NextGen Healthcare shareholders will receive significant immediate cash value for their shares. In addition, with Thoma Bravo as a partner, the Company will benefit from increased capital, expertise and strategic flexibility to accelerate the Company’s leadership in providing healthcare technology solutions,” said David Sides, President and Chief Executive Officer of NextGen Healthcare.
“NextGen Healthcare’s mission-critical EMR software and surround solutions are the backbone of ambulatory practices across the United States,” said A.J. Rohde, a Senior Partner at Thoma Bravo.
